Omics-To-Therapy (OTT) Group

The Omics-To-Therapy (OTT) Group is dedicated to translating multi-omics discoveries into precision cancer therapies. We integrate genomics, transcriptomics, epigenomics, and proteomics with computational biology and drug discovery to bridge the gap between molecular insights and clinical applications.

We are an integral part of Sri Shankara National Centre for Cancer Prevention and Research (SSNCCPR), under the Sri Shankara Cancer Foundation (SSCF), Bangalore.


Funding 1
Funding 2
Funding 3